What about prophylactic surgery in BRCA1/BRCA2 mutation carriers? Observations from an Italian pilot study

Breast J. 2017 Nov;23(6):766-767. doi: 10.1111/tbj.12825. Epub 2017 Jun 2.

Authors

Francesca Dionigi^{1

2}, Marina Maffoni¹, Alberta Ferrari³, Carlos Alberto Garcia-Etienne³, Alice Ricciardi¹, Elisabetta Razzaboni⁴, Adele Sgarella³, Eugenia Trotti⁵

Affiliations

¹ Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
² Psychological Medicine, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
³ Breast Center, Department of Surgical Sciences, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Pavia, Italy.
⁴ Policlinico di Modena, Azienda Ospedaliero-Universitaria, Modena, Italy.
⁵ Department of Medicine and Surgery, University of Insubria, Varese, Italy.

PMID: 28574632
DOI: 10.1111/tbj.12825

No abstract available

Publication types

Letter

MeSH terms

Adult
BRCA1 Protein / genetics*
BRCA2 Protein / genetics*
Breast Neoplasms / psychology
Breast Neoplasms / surgery*
Female
Genetic Predisposition to Disease*
Humans
Italy
Mutation
Ovariectomy
Pilot Projects
Prophylactic Mastectomy / statistics & numerical data*
Prophylactic Surgical Procedures / statistics & numerical data
Salpingectomy
Surveys and Questionnaires
Treatment Outcome

Substances

BRCA1 Protein
BRCA1 protein, human
BRCA2 Protein
BRCA2 protein, human